PX(PX)
PX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $351M | $391M |
| Low | $341M | $385M |
| High | $361M | $397M |
| EBITDA Avg | $115M | $128M |
| Low | $112M | $126M |
| High | $118M | $130M |
| EBIT Avg | $68M | $76M |
| Low | $66M | $75M |
| High | $70M | $77M |
| Net Income Avg | $515M | $597M |
| Low | $506M | $575M |
| High | $524M | $619M |
| EPS Avg | $1.09 | $1.26 |
| Low | $1.07 | $1.22 |
| High | $1.11 | $1.31 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $86M | $91M | $91M | $98M | $102M | $105M |
| Low | $86M | $91M | $91M | $98M | $102M | $105M |
| High | $86M | $91M | $91M | $98M | $102M | $105M |
| EBITDA Avg | $28M | $30M | $30M | $32M | $33M | $34M |
| Low | $28M | $30M | $30M | $32M | $33M | $34M |
| High | $28M | $30M | $30M | $32M | $33M | $34M |
| EBIT Avg | $17M | $18M | $18M | $19M | $20M | $20M |
| Low | $17M | $18M | $18M | $19M | $20M | $20M |
| High | $17M | $18M | $18M | $19M | $20M | $20M |
| Net Income Avg | $33M | $34M | $36M | $39M | $41M | $42M |
| Low | $33M | $34M | $36M | $39M | $41M | $42M |
| High | $33M | $34M | $36M | $39M | $41M | $42M |
| EPS Avg | $0.28 | $0.29 | $0.31 | $0.33 | $0.35 | $0.36 |
| Low | $0.28 | $0.29 | $0.31 | $0.33 | $0.35 | $0.36 |
| High | $0.28 | $0.29 | $0.31 | $0.33 | $0.35 | $0.36 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |